NASDAQ:TCRX
USD
7.69
- (-0.8%)
TSCAN THERAPEUTICS, INC.
Industry: Biotechnology
End of Day: 15 April 2024 GMT-4
USD 7.690
- (-0.8%)
End of Day: 15 April 2024 GMT-4
Industry: Biotechnology
Quote
Market Cap
-
1M Daily Avg. Vol
-
3Y P/B Range
-
52W Range
-
3Y P/S Range
-
3Y DivYield Range
-
Company Info
more
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's l...
Key Ratios
more
Income
more
Total Revenues (USD, MM)
-
Net Income (USD, MM)
-
Net Margin
-
Balance Sheet
more
Total Assets (USD, MM)
-
Total Liabilities (USD, MM)
-
Book Value Per Share
-
Cash Flow
more
Operations (USD, MM)
-
Investing (USD, MM)
-
Financing (USD, MM)
-
Make Smart Investment Choices
8BIT Global Pte Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
